Dianthus Therapeutics, Inc.: capex

Value{"amount": 118000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2021-01-01 – 2021-06-30
Statuscurrent
EntityDianthus Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-21-237060 · Open the official SEC filing →
Retrieved: 2026-08-19T17:19:29.697269+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001690585/capex/2021-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/95a0891f-7c7d-4e46-8e48-21b882938d5b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies